Competition on ALS Prediction - Deadline: October 15, 2012

Prize4Life challenge, in which the progression of ALS is to be predicted on the basis of patient data

The DREAM-Phil Bowen ALS Prediction Prize4Life Challenge

The Prize4Life organization is awarding a new prize, in which the progression of ALS is to be predicted on the basis of a database on patient data.

Here is a short description of the competition by the organizers:

Later today we are launching a prize competition around a unique database of clinical trials data we have been building over the past two years. The full database will house the largest open access clinical trial dataset ever built and will include over 7000 records of ALS patients from past clinical trials, spanning more than a year of data. In ALS, as you may know, unfortunately most patients die very quickly (2-5 years from the time of diagnosis), but some patients, like Stephen Hawking, survive much longer. In the challenge, linked to the database and launching on July 11st, we ask participants to use the data we have collected to predict the future progression of disease for individual patients. We are collaborating with IBM’s DREAM (Dialogue for Reverse Engineering Assessments and Methods), with clinicians at Mass General, and with the Department of Biostatistics at Mass General and are sponsored by Nature, The Economist and Popular science.

All details can be found at:

https://www.innocentive.com/ar/challenge/9933047